ArticlePloS one2015

Cost-Effectiveness Analysis of Universal Vaccination of Adults Aged 60 Years with 23-Valent Pneumococcal Polysaccharide Vaccine versus Current Practice in Brazil.

Patrícia Coelho de Soárez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.